DENVER- February 6, 2025 - Today, the Global Down Syndrome Foundation (GLOBAL) announced Multiplatinum artist and actor ...

New Mexico’s higher education institutions are adjusting to the Trump administration’s announcement that it will begin ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ACCES ...

This Press Release updates numerical list in reference sectionTheralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of th ...

Colorado, especially to those of you trying to keep up with rapidly changing federal funding policy. Yesterday's explosion of chaos in Colorado around the Trump administration's order freezing a bunch ...

The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.

The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...

Tabak, a dentist and researcher, was appointed as the NIH’s principal deputy director in 2010. His tenure spans four presidential administrations, and includes a nearly two-year stint as the ...

His research has been funded by the NIH. Working in an historical archive is a lot like laboratory science. Lots of noise and too little signal. You can spend a day plowing through routine ...

The NIH, the largest funder of biomedical research in the U.S., will limit funding for indirect costs to 15%. Indirect costs cover expenses like building maintenance and administrative salaries.

“Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.” The NIH is the primary source of federal funding for medical ...

Research leaders contend that the NIH decision will damage America’s ability to compete with China and other nations on the frontier of biomedicine. Although it is framed as a simple cost ...